About
The Journal "Obstetrics and Gynecology"Journal HistoryAims and ScopePolicies on Conflict of Interest, Human and Animal Rights, and Informed ConsentEditorial ProcessData sharing statementAdvertising PolicyThe Process for Handling Cases Requiring Corrections, Retractions, and Editorial Expressions of ConcernEditorial BoardEditorial CounsilInformation for ProfessionalsNewsContacts
ArchiveEthical StandardsSubscription
For authors
InstructionsInformed consent policyContract offerEASE GuidelinesICJME CriteriaWAME Recommendations on ChatGPT and Chatbots in Relation to Scholarly Publications
Reviewing
About
The Journal "Obstetrics and Gynecology"Journal HistoryAims and ScopePolicies on Conflict of Interest, Human and Animal Rights, and Informed ConsentEditorial ProcessData sharing statementAdvertising PolicyThe Process for Handling Cases Requiring Corrections, Retractions, and Editorial Expressions of ConcernEditorial BoardEditorial CounsilInformation for ProfessionalsNewsContacts
ArchiveEthical StandardsSubscription
For authors
InstructionsInformed consent policyContract offerEASE GuidelinesICJME CriteriaWAME Recommendations on ChatGPT and Chatbots in Relation to Scholarly Publications
Reviewing
Logout
Obstetrics and Gynegology2019№3
Molecular mechanisms of and risk...

Molecular mechanisms of and risk factors for endometriosis

DOI
https://dx.doi.org/10.18565/aig.2019.3.26-31

Ponomarenko I.V., Polonikov A.V., Churnosov M.I.

1 Belgorod State National Research University, Belgorod, Russia; 2 Kursk State Medical University, Ministry of Health of Russia, Kursk, Russia
The paper carries out a systems analysis of the data available in the current literature on the etiopathogenesis and risk factors of endometriosis. It considers the current data of foreign and Russian articles found in Pubmed on this topic. The main etiological hypotheses and molecular mechanisms of endometriosis are given; risk factors for its development are described. According to modern concepts, endometriosis is an etiologically heterogeneous disease, the basis of which is a complex set of hormonal, immunological, inflammatory, genetic, and epigenetic mechanisms. The risk factors for endometriosis are being actively studied, but the results obtained are ambiguous and often contradictory.

Keywords

endometriosis
etiology
pathogenesis
risk factors
Full text (in Russian)

References

  1. Адамян Л.В., ред. Эндометриоз: диагностика, лечение и реабилитация. Федеральные клинические рекомендации по ведению больных. М.: Российское общество акушеров-гинекологов, ФГБУ «Научный Центр акушерства, гинекологии и перинатологии им. В. И. Кулакова» Минздрава РФ; 2013. 66с. [Adamyan L.V., ed. Endometriosis: diagnosis, treatment and rehabilitation. Federal clinical guidelines for the management of patients. M .: Russian Society of Obstetricians and Gynecologists, FSBI Scientific Center for Obstetrics, Gynecology and Perinatology. V. I. Kulakov, Ministry of Health of the Russian Federation; 2013. 66p. (in Russian)]
  2. Anglesio M.S., Papadopoulos N., Ayhan A., Nazeran T.M., Noë M., Horlings H.M. et al. Cancer-associated mutations in endometriosis without cancer. N. Engl. J. Med. 2017; 376(19): 1835-48. https://dx.doi.org/10.1056/NEJMoa1614814.
  3. Surrey E., Carter C.M., Soliman A.M., Khan S., DiBenedetti D.B., Snabes M.C. Patient-completed or symptom-based screening tools for endometriosis: a scoping review. Arch. Gynecol. Obstet. 2017; 296(2): 153-65. https://dx.doi.org/10.1007/s00404-017-4406-9.
  4. Soliman A.M., Yang H., Du E.X., Kelley C., Winkel C. The direct and indirect costs associated with endometriosis: a systematic literature review. Hum. Reprod. 2016; 31(4): 712-22. https://dx.doi.org/10.1093/humrep/dev335.
  5. Киселев В.И., Сидорова И.С., Унанян А.Л., Муйжнек Е.Л. Гиперпластические процессы органов женской репродуктивной системы: теория и практика. М.: МЕДПРАКТИКА-М; 2010. 468с. [Kiselev V.I., Sidorova I.S., Unanyan A.L., Muizhnek E.L. Hyperplastic processes of the organs of the female reproductive system: theory and practice. M .: MEDPRAKTIKA-M; 2010. 468p. (in Russian)]
  6. Адамян Л.В., Фархат К.Н., Макиян З.Н., Савилова А.М. Молекулярно-биологическая характеристика эутопического и эктопического эндометрия (обзор литературы). Проблемы репродукции. 2015; 21(5): 8-16. [Adamyan L.V.,Farhat K.N., Makiyan Z.N., Savilova A.M. Molecular-biological characteristics of eutopic and ectopic endometria (literature review). Reproduction problems. 2015; 21 (5): 8-16. (in Russian)] https://dx.doi.org/10.17116/repro20152158-16.
  7. Mehedintu C., Plotogea M., Ionescu S., Antonovici M. Endometriosis still a challenge. J. Med. Life. 2014; 7(3): 349-57.
  8. Sourial S., Tempest N., Hapangama D.K. Theories on the pathogenesis of endometriosis. Int. J. Reprod. Med. 2014; 2014: 179515. https://dx.doi.org/10.1155/2014/179515.
  9. Ahn S.H., Monsanto S.P., Miller C., Singh S.S., Thomas R., Tayade C. Pathophysiology and immune dysfunction in endometriosis. Biomed. Res. Int. 2015; 2015: 795976. https://dx.doi.org/10.1155/2015/795976.
  10. Ярмолинская М.И., Айламазян Э.К. Генитальный эндометриоз. Различные грани проблемы. СПб.: Эко-Вектор; 2017. 615с. [Yarmolinskaya M.I., Aylamazyan E.K. Genital endometriosis. Different facets of the problem. SPb .: Eco-Vector; 2017. 615p. (in Russian)]
  11. Адамян Л.В., Азнаурова Я.Б. Молекулярные аспекты патогенеза эндометриоза. Проблемы репродукции. 2015; 21(2): 66-77. [Adamyan L.V., Aznaurova Ya.B. Molecular aspects of the pathogenesis of endometriosis. Reproduction problems. 2015; 21 (2): 66-77. (in Russian)] https://dx.doi.org/10.17116/repro201521266-77.
  12. Zhao Y., Gong P., Chen Y., Nwachukwu J.C., Srinivasan S., Ko C. et al. Dual suppression of estrogenic and inflammatory activities for targeting of endometriosis. Sci. Transl. Med. 2015; 7(271): 271ra9. https://dx.doi.org/10.1126/scitranslmed.3010626.
  13. Han S.J., Jung S.Y., Wu S.-P., Hawkins S.M., Park M.J., Kyo S. et al. Estrogen Receptor β modulates apoptosis complexes and the inflammasome to drive the pathogenesis of endometriosis. Cell. 2015; 163(4): 960-74. https://dx.doi.org/10.1016/j.cell.2015.10.034.
  14. Monsivais D., Dyson M.T., Yin P., Coon J.S., Navarro A., Feng G. et al. ERβ- and prostaglandin E2-regulated pathways integrate cell proliferation via Ras-like and estrogen-regulated growth inhibitor in endometriosis. Mol. Endocrinol. 2014; 28(8): 1304-15. https://dx.doi.org/10.1210/me.2013-1421.
  15. Salmeri F.M., Laganà A.S., Sofo V., Triolo O., Sturlese E., Retto G. et al. Behavior of tumor necrosis Factor-α and tumor necrosis factor receptor 1/tumor necrosis factor receptor 2 system in mononuclear cells recovered from peritoneal fluid of women with endometriosis at different stages. Reprod. Sci. 2015; 22(2): 165-72. https://dx.doi.org/10.1177/1933719114536472.
  16. Sikora J., Mielczarek-Palacz A., Kondera-Anasz Z. Imbalance in cytokines from interleukin-1 family - role in pathogenesis of endometriosis. Am. J. Reprod. Immunol. 2012; 68(2): 138-45. https://dx.doi.org/10.1111/j.1600-0897.2012.01147.x.
  17. Nothnick W., Alali Z. Recent advances in the understanding of endometriosis: the role of inflammatory mediators in disease pathogenesis and treatment. F1000Res. 2016; 5. pii: F1000 Faculty Rev-186. https://dx.doi.org/10.12688/f1000research.7504.1.
  18. Burney R.O., Giudice L.C. Pathogenesis and pathophysiology of endometriosis. Fertil. Steril. 2012; 98(3): 511-9. https://dx.doi.org/10.1016/j.fertnstert.2012.06.029.
  19. Rahmioglu N., Montgomery G.W., Zondervan K.T. Genetics of endometriosis. Womens Health (Lond.). 2015; 11(5): 577-86. https://dx.doi.org/10.2217/whe.15.41.
  20. Baranov V., Malysheva O., Yarmolinskaya M. Pathogenomics of endometriosis development. Int. J. Mol. Sci. 2018; 19(7). pii: E1852. https://dx.doi.org/10.3390/ijms19071852.
  21. Радзинский В.Е., Алтухова О.Б. Молекулярно-генетические детерминанты бесплодия при генитальном эндометриозе. Научные результаты биомедицинских исследований. 2018; 4(3): 21-30. [Radzinsky V.E., Altuchova O.B. Molecular-genetic determinants of infertility in genital endometryosis. Research Results in Biomedicine. 2018;4(3):21-30. (in Russian)]. https://dx.doi.org/10.18413/2313-8955-2018-4-3-0-3.
  22. Matalliotakis M., Zervou M.I., Eliopoulos E., Matalliotaki C., Rahmioglu N., Kalogiannidis I. et al. The role of IL‑16 gene polymorphisms in endometriosis. Int. J. Mol. Med. 2018; 41(3): 1469-76.
  23. Демакова Н.А. Молекулярно-генетические характеристики пациенток с гиперплазией и полипами эндометрия. Научный результат. Медицина и фармация. 2018; 4(2):26-39. [Demakova N.A. Molecular and genetic characteristics of patients with hyperplasia and endometric polyps. Research Result. Medicine and Pharmacy. 2018; 4 (2): 26-39. (in Russian)]. DOI: 10.18413/2313-8955-2018-4-2-0-4
  24. Рудых Н.А., Сиротина С.С. Генетические соотношения русских и украинских популяций Белгородской области. Научный результат. Медицина и фармация. 2015; 1(3): 72-79. [Rudyh N.A., Sirotina S.S. Genetic interrelations of Russian and Ukrainian populations of Belgorod region]. Research Result. Medicine and Pharmacy. 2015; 1(3): 72-79. (in Russian)]. DOI: 10.18413/2313-8955-2015-1-3-72-79
  25. Сорокина И.Н., Рудых Н.А,. Безменова И.Н., Полякова И.С. Популяционно-генетические характеристики и генетико-эпидемиологическое исследование ассоциаций генов-кандидатов с мультифакториальными заболеваниями. Научные результаты биомедицинских исследований. 2018; 4 (4): 20-30. [Sorokina I.N., Rudykh N.A., Bezmenova I.N., et al. Population genetic characteristics and genetic epidemiological research of candidate genes associations with multifactorial diseases. Research Results in Biomedicine. 2018; 4 (4): 20-30 (In Russian)]. DOI: 10.18413/2313-8955-2018-4-4-0-3
  26. Пономаренко И.В. Отбор полиморфных локусов для анализа ассоциаций при генетико-эпидемиологических исследованиях. Научный результат. Медицина и фармация. 2018;4(2):40-54. [Ponomarenko I.V. Selection of polymorphic loci for association analysis in genetic-epidemiological studies. Research Result. Medicine and Pharmacy. 2018;4(2):40-54. (in Russian)]. DOI: 10.18413/2313-8955-2018-4-2-0-5
  27. Yotova I., Hsu E., Do C., Gaba A., Sczabolcs M., Dekan S. et al. Epigenetic alterations affecting transcription factors and signaling pathways in stromal cells of endometriosis. PLoS One. 2017; 12(1): e0170859. https://dx.doi.org/10.1371/journal.pone.0170859.
  28. Borghese B., Zondervan K.T., Abrao M.S., Chapron C., Vaiman D. Recent insights on the genetics and epigenetics of endometriosis. Clin. Genet. 2017; 91(2): 254-64. https://dx.doi.org/10.1111/cge.12897.
  29. Nothnick W.B. Non-coding RNAs in uterine development, function and disease. Adv. Exp. Med. Biol. 2016; 886: 171-89. https://dx.doi.org/10.1007/978-94-017-7417-8_9.
  30. Nnoaham K.E., Webster P., Kumbang J., Kennedy S.H., Zondervan K.T. Is early age at menarche a risk factor for endometriosis? A systematic review and meta-analysis of case-control studies. Fertil. Steril. 2012; 98(3): 702-12. e6. https://dx.doi.org/10.1016/j.fertnstert.2012.05.035.
  31. Peterson C.M., Johnstone E.B., Hammoud A.O., Stanford J.B., Varner M.W., Kennedy A. et al. Risk factors associated with endometriosis: importance of study population for characterizing disease in the ENDO Study. Am. J. Obstet. Gynecol. 2013; 208(6): 451. e1-11. https://dx.doi.org/10.1016/j.ajog.2013.02.040.
  32. Ashrafi M., Sadatmahalleh S.J., Akhoond M.R., Talebi M. Evaluation of risk factors associated with endometriosis in infertile women. Int. J. Fertil. Steril. 2016; 10(1): 11-21.
  33. Wei M., Cheng Y., Bu H., Zhao Y., Zhao W. Length of menstrual cycle and risk of endometriosis: a meta-analysis of 11 case–control studies. Medicine (Baltimore). 2016; 95(9): e2922. https://dx.doi.org/10.1097/MD.0000000000002922.
  34. Parazzini F., Esposito G., Tozzi L., Noli S., Bianchi S. Epidemiology of endometriosis and its comorbidities. Eur. J. Obstet. Gynecol. Reprod. Biol. 2017; 209: 3-7. https://dx.doi.org/10.1016/j.ejogrb.2016.04.021.
  35. Parazzini F., Mais V., Cipriani S., Busacca M., Venturini P. Determinants of adenomyosis in women who underwent hysterectomy for benign gynecological conditions: results from a prospective multicentric study in Italy. Eur. J. Obstet. Gynecol. Reprod. Biol. 2009; 143(2): 103-6. https://dx.doi.org/10.1016/j.ejogrb.2008.12.010.
  36. Moini A., Malekzadeh F., Amirchaghmaghi E., Kashfi F., Akhoond M.R., Saei M. et al. Risk factors associated with endometriosis among infertile Iranian women. Arch. Med. Sci. 2013; 9(3): 506-14. https://dx.doi.org/10.5114/aoms.2013.35420.
  37. Buck Louis G.M., Hediger M.L., Peña J.B. Intrauterine exposures and risk of endometriosis. Hum. Reprod. 2007; 22(12): 3232-6. https://dx.doi.org/10.1093/humrep/dem338.
  38. Backonja U., Buck Louis G.M., Lauver D.R. Overall adiposity, adipose tissue distribution, and endometriosis: a systematic review. Nurs. Res. 2016; 65(2): 151-66. https://dx.doi.org/10.1097/NNR.0000000000000146.
  39. Yong L., Weiyuan Z. Association between body mass index and endometriosis risk: a meta-analysis. Oncotarget. 2017; 8(29): 46928-36. https://dx.doi.org/10.18632/oncotarget.14916.
  40. Vercellini P., Buggio L., Somigliana E., Barbara G., Viganò P., Fedele L. Attractiveness of women with rectovaginal endometriosis: a case-control study. Fertil. Steril. 2013; 99(1): 212-8. https://dx.doi.org/10.1016/j.fertnstert.2012.08.039.
  41. Sahmani M., Ghaleh T.D., Darabi M., Darabi M., Rashvand Z., Najafipour R. I405V polymorphism of CETP gene and lipid profile in women with endometriosis. Gynecol. Endocrinol. 2013; 29(7): 712-5. https://dx.doi.org/10.3109/09513590.2013.797396.
  42. Parazzini F., Viganò P., Candiani M., Fedele L. Diet and endometriosis risk: a literature review. Reprod. Biomed. Online. 2013; 26(4): 323-36. https://dx.doi.org/10.1016/j.rbmo.2012.12.011.
  43. Chiaffarino F., Bravi F., Cipriani S., Parazzini F., Ricci E., Viganò P. et al. Coffee and caffeine intake and risk of endometriosis: a meta-analysis. Eur. J. Nutr. 2014; 53(7): 1573-9. https://dx.doi.org/10.1007/s00394-014-0662-7.
  44. Parazzini F., Cipriani S., Bravi F., Pelucchi C., Chiaffarino F., Ricci E. et al. A metaanalysis on alcohol consumption and risk of endometriosis. Am. J. Obstet. Gynecol. 2013; 209(2): 106. e1-10. https://dx.doi.org/10.1016/j.ajog.2013.05.039

Received 12.03.2018

Accepted 20.04.2018

About the Authors

Ponomarenko, Irina V., MD, associate professor of the Department of Biomedical Disciplines of the Medical Institute, Belgorod State National Research University.
Address: Russia, 308015, Belgorod, Pobedy str. 85. Tel.: +74722301383. E-mail: ponomarenko_i@bsu.edu.ru. https://orcid.org/0000-0002-5652-0166.
Polonikov, Alexey V., MD, Professor, Head of the Department of Biology, Medical Genetics and Ecology, Kursk State Medical University, Ministry of Health of Russia.
Address: Russia, 305041, Kursk, K. Marx str. 3. Tel.: +74712588147. E-mail: polonikovav@kursksmu.net.
Churnosov, Mikhail I., MD, professor, head of the Department of Biomedical Disciplines Medical Faculty, Belgorod State National Research University.
Address: Russia, 308015, Belgorod, Pobedy str. 85. Tel.: +74722301383. E-mail: churnosov@bsu.edu.ru. http://orcid.org/0000-0003- 1254-6134.

For citation: Ponomarenko I.V., Polonikov A.V., Churnosov M.I. Molecular mechanisms of and risk factors for endometriosis. Akusherstvo i Ginekologiya/Obstetrics and Gynecology.2019; (3): 26-31. (in Russian)
https://dx.doi.org/10.18565/aig.2019.3.26-31

Similar Articles

№4 / 2023
Barinova E.R., Aruytin D.G.
Predictors of infertility
№5 / 2023
Chernukha G.E., Pronina V.A.
Prolonged hormonal therapy for endometriosis: how to make the right choice?
№7 / 2023
Senina D.N., Chuprynin V.D., Asaturova A.V., Chursin V.V., Buralkina N.A.
Possible predictors of recurrence risk of deep endometriosis
№11 / 2023
Chernukha G.E., Pronina V.A., Solopova A.E.
Modern possibilities for optimizing the diagnosis and therapy of ovarian endometriomas
№2 / 2024
Alieva P.M., Dumanovskaya M.R., Solopova A.E., Smetnik A.A., Chuprynin V.D., Pavlovich S.V.
The features of the course of retrocervical endometriosis
By continuing to use our site, you consent to the processing of cookies that ensure the proper functioning of the site.